Tobacco Dependence: Clinical Trials

16 trials for Tobacco Dependence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 recruiting, 2 unknown, 1 active not recruiting. 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 416Completed 11, Recruiting 2, Unknown 2, Active not recruiting 1

Follow Tobacco Dependence: new trials by email Literature Review of Tobacco Dependence trials Research Report on Tobacco Dependence

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
Motivation-Phase Varenicline, Motivation-Phase Nicotine Mini-Lozenge, Cessation-Phase Combination Nicotine Replacement Therapy (NRT) - Veterans, Tobacco Use Disorder
Phase 4RecruitingVA Office of Research and Development4002026-08-172026-08-31
C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics
C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker - Tobacco Dependence
Phase 4Active not recruitingJohns Hopkins University302025-12-102026-07-06
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
Nicotine Replacement Therapy (NRT), Wellness Coaching - Tobacco Cessation, Tobacco Abstinence
Phase 4RecruitingUniversity of California, San Francisco1502025-11-142025-11-21
C-Raven, a Virtual Tobacco Cessation Intervention in the Community
C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker - Tobacco Dependence
Phase 4CompletedJohns Hopkins University102024-10-302026-02-02
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker - Tobacco Dependence
Phase 4CompletedJohns Hopkins University52024-04-302025-09-10
Varenicline OTC Trial on Efficacy and Safety
1.0mg Varenicline b.i.d., 0.5mg Varenicline b.i.d., 0.0mg placebo Varenicline b.i.d. - Tobacco Dependence, Withdrawal Symptoms
Phase 4CompletedArizona State University3132018-05-072024-09-19
UW Quitting Using Intensive Treatment Study (QUITS)
Varenicline, Nicotine patch, Placebo Patch - Tobacco Dependence
Phase 4CompletedUniversity of Wisconsin, Madison12512017-11-112023-01-23
Varenicline for Co-occurring Cannabis and Tobacco Use
Standard clinical care first, followed by standard clinical care and varenicline, Standard clinical care and varenicline first, followed by standard clinical care - Cannabis Dependence, Tobacco Dependence
Phase 4CompletedAlbert Einstein College of Medicine72015-01-012024-09-24
Effectiveness of an E-mail Tracking Intervention Among the Continued Abstinence of Tobacco Consumption
electronic mail - Tobacco Dependence, Cessation of Smoking
Phase 4UnknownFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina10642012-12-012014-06-19
tDCS as Add on Therapy for Treatment of Tobacco Dependence by Standardized Behaviour Therapy
tDCS, standardised behavioural therapy - Smoking Cessation, Tobacco Dependence
Phase 4UnknownLudwig-Maximilians - University of Munich402012-07-012012-11-27
Evaluation of the Safety Profile, Quit and Reduction Rate After NicoretteĀ® Gum and Patch Treatment
Nicotine Gum, Nicotine Patch - Tobacco Dependence
Phase 4CompletedMcNeil AB3002009-02-012012-07-13
The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia
Hihg-doseNRT, Low-dose NRT, bupropion - Tobacco Dependence, Schizophrenia
Phase 4CompletedYu-Li Hospital3602006-01-012010-04-14
Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation
sustained-release bupropion (Zyban(R)), Psychodynamic Model Training (R) = PDM(R) - Nicotine Dependence, Substance Abuse
Phase 4CompletedMedical University Innsbruck7792005-07-012007-06-11
Smoking Cessation Intervention: Effectiveness in Primary Care
nicotine patch, nicotine lozenge, bupropion - Tobacco Dependence
Phase 4CompletedUniversity of Wisconsin, Madison13462004-09-012015-10-14
Bupropion Alone or Combined With Nicotine Gum
bupropion + nicotine gum, Active bupropion-Placebo gum, Placebo bupropion-Placebo gum - Tobacco Dependence
Phase 4CompletedUniversity of Wisconsin, Madison6082001-01-012016-12-06
Bupropion SR Plus Counseling for Smoking Cessation
Active bupropion + counseling, Active bupropion, No counseling, Placebo medication + counseling - Tobacco Dependence, Smoking
Phase 4CompletedUniversity of Wisconsin, Madison4632001-01-012016-01-27

Narrower conditions

Tobacco Use Disorder (16)  ·  Smoking Cessation (6)  ·  Cigarette Smoking (1)  ·  Marijuana Abuse (1)  ·  Schizophrenia (1)  ·  Smoking (1)  ·  Smoking Reduction (1)  ·  Substance Withdrawal Syndrome (1)  ·  Substance-Related Disorders (1)  ·  Tobacco Use (1)  ·  Tobacco Use Cessation (1)

Broader conditions

Chemically-Induced Disorders (16)  ·  Mental Disorders (16)  ·  Substance-Related Disorders (15)  ·  Behavior (9)  ·  Health Behavior (8)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Smoking (1)  ·  Tobacco Smoking (1)  ·  Tobacco Use (1)

Interventions

Tobacco Use Cessation Devices (6)  ·  Bupropion (3)  ·  Community Health Workers (3)  ·  Nicotine Chewing Gum (3)  ·  Varenicline (3)  ·  Nicotine (2)  ·  Nicotine Replacement Therapy (2)  ·  Counseling (1)  ·  Transcranial Direct Current Stimulation (1)  ·  Transdermal Patch (1)

Sponsors

University of Wisconsin, Madison (4)  ·  Johns Hopkins University (3)  ·  Albert Einstein College of Medicine (1)  ·  Arizona State University (1)  ·  Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  McNeil AB (1)  ·  Medical University Innsbruck (1)  ·  University of California, San Francisco (1)  ·  VA Office of Research and Development (1)  ·  Yu-Li Hospital (1)

Countries

United States (10)  ·  Austria (1)  ·  China (1)  ·  Germany (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Alejandra Ellison-Barnes, MD (2)  ·  Timothy B Baker, PhD (2)  ·  Frank Padberg, PD Dr. (1)  ·  Gerald Zernig, M.D. (1)  ·  Jackie Mao (1)  ·  Jeanne Clark, MD (1)  ·  Jessica Megan Cook, PhD (1)  ·  Lourdes Clemente, MD (1)  ·  Marc Casajuana, Economist (1)

Results publications

PMID 37230961, PMID 17763111, PMID 18418793, PMID 20008701, PMID 22608375, PMID 34665204, PMID 42166859

NIH funding

P50DA019706 (2), K23DA025736 (1), P50CA084724 (1), R01DA044125 (1), R01HL109031 (1), R25DA023021 (1), R25GM104547 (1)